0001968582-23-000862.txt : 20231227 0001968582-23-000862.hdr.sgml : 20231227 20231227171207 ACCESSION NUMBER: 0001968582-23-000862 CONFORMED SUBMISSION TYPE: 144 PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20231227 DATE AS OF CHANGE: 20231227 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: KalVista Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001348911 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 200915291 STATE OF INCORPORATION: DE FISCAL YEAR END: 0430 FILING VALUES: FORM TYPE: 144 SEC ACT: 1933 Act SEC FILE NUMBER: 001-36830 FILM NUMBER: 231518708 BUSINESS ADDRESS: STREET 1: 55 CAMBRIDGE PARKWAY STREET 2: SUITE 901E CITY: CAMBRIDGE STATE: MA ZIP: 02142 BUSINESS PHONE: (857) 999-0075 MAIL ADDRESS: STREET 1: 55 CAMBRIDGE PARKWAY STREET 2: SUITE 901E CITY: CAMBRIDGE STATE: MA ZIP: 02142 FORMER COMPANY: FORMER CONFORMED NAME: Carbylan Therapeutics, Inc. DATE OF NAME CHANGE: 20140916 FORMER COMPANY: FORMER CONFORMED NAME: Carbylan Biosurgery, Inc DATE OF NAME CHANGE: 20130102 FORMER COMPANY: FORMER CONFORMED NAME: Carbylan Biosurgery Inc DATE OF NAME CHANGE: 20060105 REPORTING-OWNER: COMPANY DATA: COMPANY CONFORMED NAME: Crockett Thomas Andrew CENTRAL INDEX KEY: 0001690920 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 144 MAIL ADDRESS: STREET 1: BUILDING 227, TETRICUS SCIENCE PARK STREET 2: PORTON DOWN, SALISBURY CITY: WILTSHIRE STATE: X0 ZIP: SP4 0JQ 144 1 primary_doc.xml 144 0001690920 XXXXXXXX LIVE 0001348911 KalVista Pharmaceuticals, Inc. 001-36830 55 CAMBRIDGE PARKWAY SUITE 901E CAMBRIDGE MA 02142 857-999-0075 Andrew Crockett Officer Common J.P. Morgan Securities LLC

390 Madison Avenue 6th Floor New York NY 10017

40000 480000 34558709 12/27/2023 Nasdaq Common 11/28/2016 Founder Shares Issuer N 40000 11/28/2016 NA Y 12/27/2023 01/31/2023 /s/ J.P. Morgan Securities LLC as agent and attorney-in-fact for Andrew Crockett.